Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dapagliflozin Versus Metformin and Their Combination in Polycystic Ovary Syndrome
Sponsor: Beni-Suef University
Summary
The aim of this study is to compare the hormonal, metabolic and clinical effects of metformin and dapagliflozin as monotherapies and the effect of both of them as a combined therapy in women with PCOs.
Official title: Effect of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic, Hormonal and Clinical Parameters in Women With Polycystic Ovary Syndrome
Key Details
Gender
FEMALE
Age Range
20 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2025-05-15
Completion Date
2026-05-30
Last Updated
2026-10-15
Healthy Volunteers
No
Conditions
Interventions
Dapagliflozin 5 MG
SGLT2 inhibitor
Metformin Hydrochloride 1000 MG
metformin
Dapagliflozin/Metformin
SGLT2 inhibitor and metformin HCl extended-release
Locations (1)
Beni-suef university
Banī Suwayf, Beni Suweif Governorate, Egypt